Net Cash Provided by (Used in) Operating Activities |
-12.9K |
USD |
-26.2% |
Mar 31, 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
15K |
USD |
+11.1% |
Mar 31, 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Investing Activities |
290 |
USD |
-99.6% |
Dec 31, 2022 |
Q4 2022 |
Common Stock, Shares Authorized |
150M |
shares |
0% |
Mar 31, 2024 |
Q1 2024 |
Common Stock, Shares, Issued |
111M |
shares |
+0.3% |
Mar 31, 2024 |
Q1 2024 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Mar 31, 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-1.4K |
USD |
+53% |
Mar 31, 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
4.9K |
USD |
-54.4% |
Mar 31, 2024 |
Q1 2024 |
Deferred Tax Assets, Valuation Allowance |
475K |
USD |
+96% |
Dec 31, 2023 |
Q4 2023 |
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Dec 31, 2023 |
Q4 2023 |
Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
-741K |
USD |
-340% |
Mar 31, 2024 |
Q1 2024 |
Deferred Tax Assets, Operating Loss Carryforwards |
475K |
USD |
+96% |
Dec 31, 2023 |
Q4 2023 |
Additional Paid in Capital |
14.4M |
USD |
+4.95% |
Mar 31, 2024 |
Q1 2024 |
Interest Expense |
495K |
USD |
-2.18% |
Mar 31, 2024 |
Q1 2024 |